Oncolys BioPharma Inc. (TYO:4588)

Japan · Delayed Price · Currency is JPY

4,040.00

+20.00 (0.50%)

Aug 27, 2026, 11:30 AM JST

Oncolys BioPharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	118,352	12,881	10,878	9,130	9,171	21,971
Market Cap Growth	596.37%	18.41%	19.14%	-0.44%	-58.26%	-19.57%
Enterprise Value	115,964	11,569	9,991	7,125	5,757	20,418
Last Close Price	4020.00	518.00	567.00	527.00	528.00	1503.00

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	4146.00	410.43	172.56	9.35	14.27	69.93
PB Ratio	66.83	4.68	7.38	4.23	2.55	10.97
P/TBV Ratio	66.83	4.68	7.38	4.23	2.55	10.97

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
EV/Sales Ratio	-	368.62	158.50	7.30	8.96	64.99

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	0.19	0.12	0.21	0.18	0.14	0.26
Net Debt / Equity Ratio	-0.57	-0.76	-0.83	-0.61	-0.82	-0.77
Net Debt / EBITDA Ratio	0.50	1.24	0.63	1.08	1.95	0.92
Net Debt / FCF Ratio	-	1.03	0.91	0.77	1.69	1.05
Asset Turnover	0.01	0.01	0.03	0.28	0.18	0.09
Inventory Turnover	-	-	2.19	35.52	40.10	6.15
Quick Ratio	5.19	10.14	4.32	6.19	8.91	5.38
Current Ratio	6.62	12.28	5.17	8.11	9.76	6.13
Return on Equity (ROE)	-110.09%	-79.73%	-106.71%	-39.94%	-57.72%	-76.78%
Return on Assets (ROA)	-55.37%	-40.26%	-51.44%	-22.01%	-26.86%	-29.41%
Return on Invested Capital (ROIC)	-345.38%	-365.97%	-351.64%	-164.69%	-276.12%	-306.97%
Return on Capital Employed (ROCE)	-108.70%	-57.30%	-116.20%	-52.50%	-39.40%	-70.90%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Earnings Yield	-1.74%	-13.08%	-17.82%	-12.58%	-17.61%	-9.54%
FCF Yield	-1.64%	-15.71%	-12.34%	-18.82%	-19.01%	-6.68%
Buyback Yield / Dilution	-21.76%	-22.67%	-2.71%	-2.44%	-17.54%	-3.41%